Double-dose Copaxone?
The Forte trial studied a double dose (40 mg) vs regular dose (20 mg) of Copaxone on relapses in 1155 relapsing-remitting MS patients over one year. The randomized, double-blind study was conducted at 136 centers in North America, Argentina, Europe and Israel.